T. Sohda

发表

Automated high-performance liquid chromatographic determination of hydroxylysylpyridinoline and lysylpyridinoline in urine using a column-switching method.

Y. Yoshimura, K. Ohnishi, M. Hamamura, 1993, Journal of chromatography.

Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compounds.

T. Sohda, Y. Momose, C. Hatanaka, 1991, Chemical & pharmaceutical bulletin.

Reduction of Insulin Resistance in Obese and/or Diabetic Animals by 5-[4-(1-Methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, Ciglitazone), a New Antidiabetic Agent

H. Iwatsuka, Z. Suzuoki, T. Sohda, 1983, Diabetes.

Novel 5-substituted-1H-tetrazole derivatives as potent glucose and lipid lowering agents.

T. Sohda, T. Maekawa, Y. Momose, 2002, Chemical & pharmaceutical bulletin.

Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals.

T. Sohda, S. Taketomi, T. Fujita, 1990, Arzneimittel-Forschung.

Studies on antidiabetic agents. Synthesis and hypoglycemic activity of 5-[4-(pyridylalkoxy)benzyl]-2,4-thiazolidinediones.

T. Sohda, Y. Momose, K. Meguro, 1990, Arzneimittel-Forschung.

Studies on antidiabetic agents. I. Synthesis of 5-[4-(2-methyl-2-phenylpropoxy)-benzyl]thiazolidine-2,4-dione (AL-321) and related compounds.

T. Sohda, T. Fujita, Y. Sugiyama, 1982, Chemical & pharmaceutical bulletin.

STUDIES ON ANTIDIABETIC AGENTS. IV. SYNTHESIS AND ACTIVITY OF THE METABOLITES OF 5-(4-(1-METHYLCYCLOHEXYLMETHOXY)BENZYL)-2,4-THIAZOLIDINEDIONE (CIGLITAZONE)

T. Sohda, K. Meguro, Y. Kawamatsu, 1985 .

Studies on antidiabetic agents. IV. Synthesis and activity of the metabolites of 5-[4-(1-methylcyclohexylmethoxy)benzyl]-2,4-thiazolidinedione (ciglitazone).

T. Sohda, K. Meguro, Y. Kawamatsu, 1984, Chemical & pharmaceutical bulletin.

Immunomodulating and articular protecting activities of a new anti-rheumatic drug, TAK-603.

Y. Ohta, T. Sohda, A. Baba, 1996, Immunopharmacology.

2-AMINO-4-PHENYLTHIAZOLE DERIVATIVES AS ANTI-ATHEROGENIC AGENTS

T. Sohda, Y. Imai, Y. Kawamatsu, 1981 .

STUDIES ON ANTIDIABETIC AGENTS. III. 5-ARYLTHIAZOLIDINE-2,4-DIONES AS POTENT ALDOSE REDUCTASE INHIBITORS

T. Sohda, E. Imamiya, K. Meguro, 1983 .

STUDIES ON ANTIDIABETIC AGENTS. II. SYNTHESIS OF 5-(4-(1-METHYLCYCLOHEXYLMETHOXY)BENZYL)THIAZOLIDINE-2,4-DIONE (ADD-3878) AND ITS DERIVATIVES.

T. Sohda, E. Imamiya, T. Fujita, 1983 .

Synthesis of peptide aldehyde derivatives as selective inhibitors of human cathepsin L and their inhibitory effect on bone resorption.

Y. Fujisawa, T. Sohda, A. Nishimura, 1998, Journal of medicinal chemistry.

Enhancement of fracture repair in rats with streptozotocin-induced diabetes by a single injection of biodegradable microcapsules containing a bone formation stimulant, TAK-778.

K. Saito, K. Notoya, T. Sohda, 2000, Journal of biomedical materials research.

Studies on disease-modifying antirheumatic drugs: synthesis of novel quinoline and quinazoline derivatives and their anti-inflammatory effect.

Y. Ohta, T. Sohda, A Baba, 1996, Journal of medicinal chemistry.

Studies on disease-modifying antirheumatic drugs. IV. Synthesis of novel thieno[2,3-b:5,4-c']dipyridine derivatives and their anti-inflammatory effect.

S. Unno, A. Mori, T. Sohda, 1999, Chemical & pharmaceutical bulletin.

Novel 5-substituted 2,4-thiazolidinedione and 2,4-oxazolidinedione derivatives as insulin sensitizers with antidiabetic activities.

M. Kawada, T. Sohda, T. Maekawa, 2002, Journal of medicinal chemistry.

Studies on disease-modifying antirheumatic drugs. III. Bone resorption inhibitory effects of ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl) quinoline-3-carboxylate (TAK-603) and related compounds.

K. Notoya, T. Sohda, A. Baba, 1999, Chemical & pharmaceutical bulletin.

New 1,4-dihydropyridine derivatives with potent and long-lasting hypotensive effect.

A. Nagaoka, T. Sohda, M. Aizawa, 1985, Chemical & pharmaceutical bulletin.

New 1,4-dihydropyridine derivatives with potent and long-lasting hypotensive effect.

A. Nagaoka, T. Sohda, M. Aizawa, 1985, Chemical & pharmaceutical bulletin.

Studies on antidiabetic agents. VI. Asymmetric transformation of (+/-)-5-[4-(1-methylcyclohexylmethoxy)benzyl]-2,4- thiazolidinedione(ciglitazone) with optically active 1-phenylethylamines.

T. Sohda, Y. Kawamatsu, K. Mizuno, 1984, Chemical & pharmaceutical bulletin.

Synthesis of novel 2-benzothiopyran and 3-benzothiepin derivatives and their stimulatory effect on bone formation.

M. Gotoh, Y. Fujisawa, K. Notoya, 1999, Journal of medicinal chemistry.

Studies on antidiabetic agents. III. 5-Arylthiazolidine-2,4-diones as potent aldose reductase inhibitors.

T. Sohda, Y. Yamamoto, E. Imamiya, 1982, Chemical & pharmaceutical bulletin.

Sustained-release microcapsules of a bone formation stimulant, TAK-778, for local injection into a fracture site.

K. Saito, T. Sohda, T. Hoshino, 2001, Journal of pharmaceutical sciences.

An asymmetric synthesis and absolute configuration of (S)-(−)-deplancheine

A. Meyers, T. Sohda, Mallory F. Loewe, 1986 .

TAK‐603 selectively suppresses Th1‐type cytokine production and inhibits the progression of adjuvant arthritis

Y. Ohta, T. Sohda, H. Makino, 1997, Immunology.

Enhancement of osteogenesis in vitro and in vivo by a novel osteoblast differentiation promoting compound, TAK-778.

M. Gotoh, K. Notoya, T. Sohda, 1999, The Journal of pharmacology and experimental therapeutics.

Studies on non-thiazolidinedione antidiabetic agents. 1. Discovery of novel oxyiminoacetic acid derivatives.

H. Imoto, T. Sohda, Y. Momose, 2002, Chemical & pharmaceutical bulletin.

[Discovery and development of a new insulin sensitizing agent, pioglitazone].

T. Sohda, T. Fujita, K. Meguro, 2002, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Studies on antidiabetic agents. II. Synthesis of 5-[4-(1-methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and its derivatives.

T. Sohda, E. Imamiya, T. Fujita, 1982, Chemical & pharmaceutical bulletin.

Studies on disease-modifying antirheumatic drugs. II. Synthesis and activity of the metabolites of ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quino line-3-carboxylate (TAK-603).

Y. Ohta, T. Sohda, A. Baba, 1998, Chemical & pharmaceutical bulletin.

Studies on Disease-Modifying Antirheumatic Drugs. Part 2. Synthesis and Activity of the Metabolites of Ethyl 4-(3,4-Dimethoxyphenyl)-6,7-dimethoxy-2- (1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603).

Y. Ohta, T. Sohda, A. Baba, 1998 .

Studies on antidiabetic agents. XII. Synthesis and activity of the metabolites of (+/-)-5(-)[p(-)[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]-2,4- thiazolidinedione (pioglitazone).

T. Sohda, K. Meguro, H. Ikeda, 1995, Chemical & pharmaceutical bulletin.

Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents.

T. Sohda, Y. Momose, T. Fujita, 1992, Journal of medicinal chemistry.